Robert Driscoll
#181 out of 1697 analysts
Wedbush
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
56.56%
Gain -5.5%
Monthly
0.42%
Yearly
5.19%
Drawdown
66.09%
$147,100.66
Equity
Holdings
$147,100.66
Cash
$0
Investment
$180,478.83
$47,100.66
Profit -$8,564.62
Realized
$80,478.83
Unrealized
-$33,378.17
Dividends
$0
$0
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-5.5%
Profit
-$8,564.62
Win %
0%
This Week
Compared To Last Week
Gain
-13.34%
Profit
-$22,648.64
Win %
0%
This Month
Compared to last month
Gain
-20.84%
Profit
-$38,724.4
Win %
0%
This Year
Compared to last year
Gain
32.26%
Profit
$35,881.13
Win %
69%
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 1006 | Longs Won 456/996 45% | Profit Factor 1.13 |
| Profitability | Shorts Won 8/10 80% | Standard Deviation $2,136.71 |
| Average Win $854.53 | Best Trade (Jul 08) $27,158.09 | Sharpe Ratio -179.69 |
| Average Loss -$644.65 | Worst Trade (Jun 07) -$18,381.78 | Z-Score -9.36 (100%) |
| Commissions $0 | Avg. Trade Length 2m 1w 4d | Expectancy $46.82 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 0.1% | 0.81% | 2.72% | 6.44% | 12.56% | 21.68% | 34.39% | 51.28% | 72.96% |
| Consecutive Losing Trades | 228 | 205 | 183 | 160 | 137 | 114 | 91 | 68 | 46 | 23 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
 ACET Adicet Bio, Inc. | 8,808.14 | $60,159.61 | $42,014.84 | - | -$18,144.77 | -30.16% | -7.198% |
 CGEM Cullinan Therapeutics, Inc. | 4,062.09 | $60,159.61 | $54,143.65 | - | -$6,015.96 | -10% | -4.793% |
 RCUS Arcus Biosciences Inc. | 2,345.4 | $60,159.61 | $50,942.17 | - | -$9,217.44 | -15.32% | -4.82% |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
2026 © Marketlog. All Rights Reserved.
